These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30891118)
1. Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders. Brogi S; Campiani G; Brindisi M; Butini S ACS Med Chem Lett; 2019 Mar; 10(3):228-236. PubMed ID: 30891118 [TBL] [Abstract][Full Text] [Related]
2. Deeper Insights into the Allosteric Modulation of Ionotropic Glutamate Receptors. Regan MC; Furukawa H Neuron; 2016 Sep; 91(6):1187-1189. PubMed ID: 27657445 [TBL] [Abstract][Full Text] [Related]
3. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders. Gregory KJ; Noetzel MJ; Niswender CM Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092 [TBL] [Abstract][Full Text] [Related]
4. Supraspinal metabotropic glutamate receptors: a target for pain relief and beyond. Palazzo E; Marabese I; de Novellis V; Rossi F; Maione S Eur J Neurosci; 2014 Feb; 39(3):444-54. PubMed ID: 24494684 [TBL] [Abstract][Full Text] [Related]
5. Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors. Fu H; Chen Z; Josephson L; Li Z; Liang SH J Med Chem; 2019 Jan; 62(2):403-419. PubMed ID: 30110164 [TBL] [Abstract][Full Text] [Related]
6. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Kew JN; Kemp JA Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895 [TBL] [Abstract][Full Text] [Related]
8. Fragment-Based Approaches for Allosteric Metabotropic Glutamate Receptor (mGluR) Modulators. Orgován Z; Ferenczy GG; Keserű GM Curr Top Med Chem; 2019; 19(19):1768-1781. PubMed ID: 31393248 [TBL] [Abstract][Full Text] [Related]
9. Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators. Pøhlsgaard J; Frydenvang K; Madsen U; Kastrup JS Neuropharmacology; 2011 Jan; 60(1):135-50. PubMed ID: 20713069 [TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Dual Negative Allosteric Modulators of Group I mGluR Family: A Shape Based Screening, ADME Prediction, Induced Fit Docking and Molecular Dynamics Approach Against Neurodegenerative Diseases. Prabhu SV; Singh SK Curr Top Med Chem; 2019; 19(29):2687-2707. PubMed ID: 31702505 [TBL] [Abstract][Full Text] [Related]
12. Methods for evaluation of positive allosteric modulators of glutamate AMPA receptors. Siuda ER; Quirk JC; Nisenbaum ES Methods Mol Biol; 2007; 403():37-57. PubMed ID: 18827986 [TBL] [Abstract][Full Text] [Related]
13. New therapeutic frontiers for metabotropic glutamate receptors. Niswender CM; Jones CK; Conn PJ Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730 [TBL] [Abstract][Full Text] [Related]
14. mGluR5 negative allosteric modulators overview: a medicinal chemistry approach towards a series of novel therapeutic agents. Rocher JP; Bonnet B; Boléa C; Lütjens R; Le Poul E; Poli S; Epping-Jordan M; Bessis AS; Ludwig B; Mutel V Curr Top Med Chem; 2011; 11(6):680-95. PubMed ID: 21261592 [TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptors as drug targets. Récasens M; Guiramand J; Aimar R; Abdulkarim A; Barbanel G Curr Drug Targets; 2007 May; 8(5):651-81. PubMed ID: 17504108 [TBL] [Abstract][Full Text] [Related]